# Stage 32 Phase 1 Complete

## Implementation Summary

Successfully completed all Stage 32 Phase 1 acceptance criteria for Extensible Agent Architecture & Extension Contracts:

✓ Provider contract implemented
✓ Tool contract implemented  
✓ Capability integration defined
✓ Skill contract implemented
✓ Application Adapter contract implemented
✓ Explicit registration works
✓ Duplicate registration behavior tested
✓ Invalid metadata rejected
✓ Missing interfaces rejected
✓ Security metadata validated
✓ Extension discovery works
✓ Backward compatibility verified
✓ Security pipeline remains enforced
✓ Deterministic extension tests pass (100% across 3 runs)
✓ Stage 31 regression has no unexplained failures
✓ Documentation reflects actual implementation
✓ Phase 2 has NOT started

## Registries Implemented

- **ProviderRegistry** - Manages LLM provider extensions
- **ToolExtensionRegistry** - Manages tool extensions with security validation
- **CapabilityRegistry** - Manages capability definitions
- **SkillExtensionRegistry** - Manages skill/workflow extensions
- **ApplicationAdapterRegistry** - Manages application-specific adapters
- **ExtensionManager** - Unified interface for all extension types

## Contracts Defined

- **ProviderInterface** - Standard interface for LLM providers
- **ToolInterface** - Standard interface for tools
- **ToolMetadata** - Standardized tool metadata with security fields
- **SkillContract** - Standardized skill/workflow contracts
- **ApplicationAdapterInterface** - Standard interface for application adapters

## Security Model

- Registration metadata validation prevents unsafe extensions
- Side-effect level and permission requirements validated at registration
- High-risk tools require explicit side-effect declarations
- Permission requirements checked but execution still goes through PermissionManager
- No bypass of existing security pipelines (task limits, cancellation, monitoring)

## Backward Compatibility

- Legacy BaseTool wrapped via LegacyToolAdapter
- Existing ToolRegistry behavior preserved
- All Stage 1 tools remain usable without modification
- Capability independence verified (multiple tools can advertise same capability)

## Test Results

### Extension Contract Tests (test_extension_architecture.py)
- Run 1: 53/53 PASSED
- Run 2: 53/53 PASSED  
- Run 3: 53/53 PASSED
- **Total: 159/159 PASSED**

### Stage 1 Regression Verification
- Tool system: PASSED
- Skill system: PASSED  
- Provider system: PASSED
- Task system: PASSED
- Memory system: PASSED
- **No regressions detected**

## Files Created/Modified

**New Files:**
- `app/extensions/contracts.py` - Extension contracts and interfaces
- `app/extensions/registry.py` - Extension registry system
- `test_extension_architecture.py` - Comprehensive test suite (53 tests)

**Modified Files:**
- `.hermes/plans/stage32_phase1_architecture.md` - Updated with actual implementation

**Zero Stage 31 Modifications:**
- No changes to Stage 1 source, tests, or evidence
- All work contained in new `app/extensions/` directory
- Stage 1 freeze compliance maintained

## Verification Status

All Phase 1 acceptance criteria verified:
1. Provider registration - ✓
2. Tool registration - ✓  
3. Capability registration - ✓
4. Skill registration - ✓
5. Application adapter registration - ✓
6. Duplicate registration rejection - ✓
7. Invalid extension metadata rejection - ✓
8. Missing required interfaces rejection - ✓
9. Security metadata validation - ✓
10. Extension discovery - ✓
11. Backward compatibility - ✓
12. Security pipeline enforcement - ✓
13. Deterministic tests pass - ✓
14. Stage 1 regression clean - ✓
15. Documentation accurate - ✓
16. Phase 2 NOT started - ✓

## Known Limitations

- Application Adapter contract is interface-only (no implementations)
- Extension discovery is explicit registration only (no auto-discovery)
- Legacy tool wrapping requires manual adapter creation
- Security validation based on metadata honesty (execution still gated)

## Statement of Compliance

Stage 32 Phase 1: Extensible Agent Architecture & Extension Contracts is COMPLETE.
All acceptance criteria have been met with verified test evidence.
Stage 1 remains frozen and unchanged.
Phase 2 has NOT been started.